Biotalys will participate in the next investor and
Ghent, Sep 21, 2021 (GLOBE NEWSWIRE) – Press release
Biotalys To Pparticipate in Uto come Investor and Stakeholder Events
Ghent, BELGIUM – 21 September 2021 – Biotalys (Euronext – BTLS), an AgTech company focused on the challenges of protecting food to enable a more sustainable and secure food supply, today announces that it will participate in the following events throughout the remainder of 2021:
Bryan-Garnier Virtual Conference on Food Technologies, September 23-24
CEO Patrice Sellès and CFO Wim Ottevaere will speak at the Bryan Garnier & Co. Food Tech Conference on Friday, September 24 at 3:00 p.m. CEST in front of an international audience of investors, with a presentation and a question-and-answer session.
Kknowledge for growth (FlandersBio), September 28
Biotalys will give a company presentation and participate in a debate on the European farm-to-fork strategy at Knowledge for Growth on Tuesday, September 28, 2021 at 2:00 p.m. CEST. The conference takes place in Ghent and brings together decision makers from the biotechnology, pharmaceutical and medical, agricultural and chemical sectors as well as investors, universities and research institutes.
VIB 25th anniversary, October 13
Biotalys will be one of the key outcomes of the event in Brussels for the 25th anniversary of VIB, the Flemish Institute of Biotechnology.
Congress Redagricola Biocontrol, October 13-15
Carlos Reyes, Field Product Development Manager at Biotalys, will speak at this online conference. The Latin American-based event will span three days, with workshops, panel discussions and keynote lectures.
VFB In 2021, October 23
Wim Ottevaere, CFO, and Toon Musschoot, Head IR & Communication, will represent Biotalys on a stand at this retail investor conference in Kinepolis, Antwerp.
FWell Technical congress, November 3-4
CEO Patrice Sellès will speak during the AgriTech session at this year’s FoodTech Congress, on Thursday, November 4, 2021.
Kepler Cheyoureal ones World Agricultural Forum, November 15
Biotalys CEO Patrice Sellès and CFO Wim Ottevaere will meet with investors at this year’s Global Agri Forum hosted by Kepler Cheuvreux (virtual format).
Deutsches Eigenkapitalforum, November 22-24
The management of Biotalys will give a presentation of the company at the Deutsches Eigenkapitalforum (EKF) on Wednesday, November 24, 2021 at 2:00 p.m. CEST (virtual format).
KBC Securities Small & Mid Cap Conference, December 9-10
Biotalys will participate in this event for institutional investors in Brussels. The CEO, Patrice Sellès, CFO, Wim Ottevaere and Toon Musschoot, Head IR & Communication, will represent the company.
– ENDS –
Biotalys is an Agricultural Technology Company (AgTech) focused on solving food protection issues with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its new AGROBODY ™ technology platform, Biotalys has developed a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to control key crop pests and diseases throughout the production chain. value, from the ground to the plate. Biotalys was founded in 2013 as a spin-off of VIB (Flemish Institute of Biotechnology) and has been listed on Euronext Brussels since July 2, 2021. The company is based in the biotech cluster in Ghent, Belgium. More information on www.biotalys.com.
For more information, please contact:
Toon Musschoot, Head of Investor Relations and Communications
T: +32 (0) 9 274 54 00
E: [email protected]
Strategic communication of the Consilium
T: +44 (0) 203 709 5700
E: [email protected]
This announcement contains statements that are or could be considered “forward-looking statements”. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “aim”, “believe”, “estimate”, “anticipate”, “expect”, “intend to” , “may”, “‘,’ plan ‘,’ continue ‘,’ in progress’, ‘possible’, ‘predict’, ‘plans’,’ target ‘,’ seek ‘,’ should ‘or’ should ‘, and contain statements made by the company regarding the expected results of its strategy. By their nature, forward-looking statements involve risks and uncertainties, and readers are cautioned that none of these forward-looking statements offer any guarantee of future performance . Actual results of Biotalys may differ materially from those predicted by forward-looking statements. Biotalys does not undertake to publish any updates or adjustments to these forward-looking statements, unless required by law to do so.